Sirtris Pharmaceuticals, Inc. 4/A
4/A · Sirtris Pharmaceuticals, Inc. · Filed Jan 4, 2008
Insider Transaction Report
Form 4/AAmended
Sinclair David
Director
Transactions
- Award
Non-Qualified Stock Option
2008-01-02+20,000→ 20,000 totalExercise: $13.00Exp: 2018-01-02→ Common Stock (20,000 underlying) - Award
Common Stock
2008-01-02+20,000→ 182,834 total
Footnotes (1)
- [F1]The options shall vest as to 25% on January 2, 2009, with the remainder to vest in equal quarterly installments over the next 12 calendar quarters ending March 31, June 30, September 30 and December 31 following January 2, 2009.